CoChat
Sign Up
Cited by 531Schizophrenia research and treatmentPsychiatric care and mental health servicesMaternal Mental Health During Pregnancy and Postpartum

The DOI matches its Crossref record; 252 of the 261 references it cites were found in a registry or an index.

Early intervention for psychosis

Open access
Marshall, Max, Rathbone, John·2011·Cochrane Database of Systematic Reviews
DOI 10.1002/14651858.cd004718.pub3PMC PMC4163966
Open this paper in CoChat — free account

Abstract

BACKGROUND: Proponents of early intervention have argued that outcomes might be improved if more therapeutic efforts were focused on the early stages of schizophrenia or on people with prodromal symptoms. Early intervention in schizophrenia has two elements that are distinct from standard care: early detection, and phase-specific treatment (phase-specific treatment is a psychological, social or physical treatment developed, or modified, specifically for use with people at an early stage of the illness).Early detection and phase-specific treatment may both be offered as supplements to standard care, or may be provided through a specialised early intervention team. Early intervention is now well established as a therapeutic approach in America, Europe and Australasia. OBJECTIVES: To evaluate the effects of: (a) early detection; (b) phase-specific treatments; and (c) specialised early intervention teams in the treatment of people with prodromal symptoms or first-episode psychosis. SEARCH STRATEGY: We searched the Cochrane Schizophrenia Group Trials Register (March 2009), inspected reference lists of all identified trials and reviews and contacted experts in the field. SELECTION CRITERIA: We included all randomised controlled trials (RCTs) designed to prevent progression to psychosis in people showing prodromal symptoms, or to improve outcome for people with first-episode psychosis. Eligible interventions, alone and in combination, included: early detection, phase-specific treatments, and care from specialised early intervention teams. We accepted cluster-randomised trials but excluded non-randomised trials. DATA COLLECTION AND ANALYSIS: We reliably selected studies, quality rated them and extracted data. For dichotomous data, we estimated relative risks (RR), with the 95% confidence intervals (CI). Where possible, we calculated the number needed to treat/harm statistic (NNT/H) and used intention-to-treat analysis (ITT). MAIN RESULTS: Studies were diverse, mostly small, undertaken by pioneering researchers and with many methodological limitations (18 RCTs, total n=1808). Mostly, meta-analyses were inappropriate. For the six studies addressing prevention of psychosis for people with prodromal symptoms, olanzapine seemed of little benefit (n=60, 1 RCT, RR conversion to psychosis 0.58 CI 0.3 to 1.2), and cognitive behavioural therapy (CBT) equally so (n=60, 1 RCT, RR conversion to psychosis 0.50 CI 0.2 to 1.7). A risperidone plus CBT plus specialised team did have benefit over specialist team alone at six months (n=59, 1 RCT, RR conversion to psychosis 0.27 CI 0.1 to 0.9, NNT 4 CI 2 to 20), but this was not seen by 12 months (n=59, 1 RCT, RR 0.54 CI 0.2 to 1.3). Omega 3 fatty acids (EPA) had advantage over placebo (n=76, 1 RCT, RR transition to psychosis 0.13 CI 0.02 to 1.0, NNT 6 CI 5 to 96). We know of no replications of this finding.The remaining trials aimed to improve outcome in first-episode psychosis. Phase-specific CBT for suicidality seemed to have little effect, but the single study was small (n=56, 1 RCT, RR suicide 0.81 CI 0.05 to 12.26). Family therapy plus a specialised team in the Netherlands did not clearly affect relapse (n=76, RR 1.05 CI 0.4 to 3.0), but without the specialised team in China it may (n=83, 1 RCT, RR admitted to hospital 0.28 CI 0.1 to 0.6, NNT 3 CI 2 to 6). The largest and highest quality study compared specialised team with standard care. Leaving the study early was reduced (n=547, 1 RCT, RR 0.59 CI 0.4 to 0.8, NNT 9 CI 6 to 18) and compliance with treatment improved (n=507, RR stopped treatment 0.20 CI 0.1 to 0.4, NNT 9 CI 8 to 12). The mean number of days spent in hospital at one year were not significantly different (n=507, WMD, -1.39 CI -2.8 to 0.1), neither were data for 'Not hospitalised' by five years (n=547, RR 1.05 CI 0.90 to 1.2). There were no significant differences in numbers 'not living independently' by one year (n=507, RR 0.55 CI 0.3 to 1.2). At five years significantly fewer participants in the treatment group were 'not living independently' (n=547, RR 0.42 CI 0.21 to 0.8, NNT 19 CI 14 to 62). When phase-specific treatment (CBT) was compared with befriending no significant differences emerged in the number of participants being hospitalised over the 12 months (n=62, 1 RCT, RR 1.08 CI 0.59 to 1.99).Phase-specific treatment E-EPA oils suggested no benefit (n=80, 1 RCT, RR no response 0.90 CI 0.6 to 1.4) as did phase-specific treatment brief intervention (n=106, 1 RCT, RR admission 0.86 CI 0.4 to 1.7). Phase-specific ACE found no benefit but participants given vocational intervention were more likely to be employed (n=41, 1 RCT, RR 0.39 CI 0.21 to 0.7, NNT 2 CI 2 to 4). Phase-specific cannabis and psychosis therapy did not show benefit (n=47, RR cannabis use 1.30 CI 0.8 to 2.2) and crisis assessment did not reduce hospitalisation (n=98, RR 0.85 CI 0.6 to 1.3). Weight was unaffected by early behavioural intervention. AUTHORS' CONCLUSIONS: There is emerging, but as ye

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd004718.pub3

Cites

252 of 252 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 261 references

Research works printed but not linked: 77

  1. Alvarez, 2005, Early intervention in antipsychotic - induced weight gain in first episode psychosis, Schizophrenia Bulletin, 31, 518
  2. Berger, 2004, Ethyl-eicosapentaenoic acid (e-epa) supplementation in early psychosis. A double-blind randomized add on standard therapy study in 80 drug- native or early treated first episode psychosis patients, Schizophrenia Research, 70, 41
  3. Berger, 2004, Ethyl-eicosapentaenoic acid (e-epa) supplementation in early psychosis, Schizophrenia Research, 67, 7
  4. Berger, 2005, Ethyl - eicosapentaenoic acid (e - epa) supplementation in early psychosis. A double - blind, randomized, placebo - controlled trial (RCT) comparing 2g e - epa versus placebo add - on therapy in 80 drug - naive or early treated first - episode psychos, Schizophrenia Bulletin, 31, 475
  5. Mcconchie, 2004, Effect of diagnostic heterogeneity on response to ethyl- eicosapentaenoic acid (epa) in first-episode psychosis, Schizophrenia Research, 67, 147
  6. Renton, 2004, Effectiveness of cognitive therapy for psychosis and implications for early intervention, Schizophrenia Research, 70, 142
  7. Bechdolf, 2004, Cognitive behavioural therapy in the early initial prodromal state of psychosis: first results, Schizophrenia Research, 67, 202
  8. Bechdolf, 2004, Cognitive-behavioural treatment (CBT) in the early initial prodromal state of psychosis: concept and practical approach, Schizophrenia Research, 70, 52
  9. Bechdolf, 2004, Cognitive behavioral therapy (CBT) in the early initial prodromal state of psychosis: first results of a randomized trial, Schizophrenia Research, 70, 62
  10. Jackson, 2005, A randomised controlled trial of CBT for early psychosis with 1 year follow-up, Australian and New Zealand Journal of Psychiatry, 39, A42
  11. Power P Bell R Mills R Herrmann-Doig T Davern M Henry L McGorry P Khademy-Deljo A A randomized controlled trial of suicide prevention therapy for young people with first episode psychosis Proceedings of the Second International Conference on Early Psychosis; 2000 March 31-2; New York, USA 2000
  12. Power, 1999, A randomised controlled trial of a suicide preventative cognitive oriented psychotherapy for suicidal young people with first episode psychosis, Schizophrenia Research, 36, 332
  13. Linszen, 2004, Early and critical period intervention in first episode schizophrenia: relapse, chronicity, early stabilisation, predictors over 4 years and new research, Schizophrenia Research, 70, 66
  14. Linszen, 1998, Early family and individual interventions and relapse in recent-onset schizophrenia and related disorders, Italian Journal of Psychiatry & Behavioural Sciences, 8, 77
  15. Linszen, 2004, Early and 3-year sustained intervention in first episode schizophrenia: relapse, stabilization and its predictors, Schizophrenia Research, 67, 18
  16. Jorgensen, 2000, Early detection and assertive community treatment of young psychotics: the opus study rationale and design of the trial, Social Psychiatry Psychiatric Epidemiology, 35, 283, 10.1007/s001270050240 · DOI
  17. Nordentoft, 2002, OPUS study: suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis. One-year follow-up of a randomised controlled trial, British Journal of Psychiatry Supplementum, 181, S98, 10.1192/bjp.181.43.s98 · DOI
  18. Nordentoft M Jeppesen P Abel M Petersen L Thorup A Christensen T Øhlenschlæger J Jorgensen P Opus-project: a randomised controlled trial of integrated psychiatric treatment in first-episode psychosis - clinical outcome improved Proceeding of the 3rd International Conference on Early Psychosis; 2002 Sep 25-28; Copenhagen, Denmark 2002 56
  19. Nordentoft, 2002, Opus-project: a randomised controlled trial of integrated psychiatric treatment in first-episode psychosis-clinical outcome improved, Schizophrenia Research, 53, 51
  20. Nordentoft, 2005, Duration of untreated psychosis predicts psychotic symptoms but not negative symptoms, Schizophrenia Bulletin, 31, 234
  21. Nordentoft M Reisby N Jeppesen P Abel M-B Kassow P Jírgensen P Opus-project: differences in treatment outcome of a randomised controlled trial of integrated psychiatric treatment of first-episode psychotic patients Proceedings of the 11th World Congress of Psychiatry; 1999 Aug 6-11; Hamburg, Germany 1999 165
  22. Petersen, 2005, The opus trial: a randomised multi-centre trial of integrated versus standard treatment for 547 first-episode psychotic patients, Schizophrenia Bulletin, 31, 531
  23. Hawkins, 2004, Neuropsychological functioning in the first episode prodrome and early psychosis, Schizophrenia Research, 70, 101
  24. Hawkins KA Addington J Keefe RS Christensen B Woods SW Zipursky RB Perkins DO McGlashan TH Effect of olanzapine versus placebo on the neuropsychological status of prodromal subjects Proceedings of the 12th Biennial Winter Workshop on Schizophrenia; 2004 Feb 7-13; Davos, Switzerland 2004
  25. McGlashan TH Intervention in the prodrome to first psychosis Proceedings of the Second International Conference on Early Psychosis; 2000 March 31-2; New York, USA 2000
  26. McGlashan, 2006, Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis, American Journal of Psychiatry, 163, 790, 10.1176/ajp.2006.163.5.790 · DOI · Paper page
  27. McGlashan TH Zipursky RB Perkins DO Addington JM Woods SW Lindborg S Breier AF Olanzapine versus pbo for the schizophrenic prodrome: one-year results Proceedings of the 156th Annual Meeting of the American Psychiatric Association; 2003 May 17-22; San Francisco, California, USA 2003
  28. Addington J Jones B Ko T Addington D Intervention strategies for families of first episode patients Proceedings of the Second International Conference on Early Psychosis; 2000 31st March - 2nd April; New York, USA 2000
  29. Alanen, 2000, The Finnish Integrated Model for Early Treatment of Schizophrenia and Related Psychoses, 235
  30. Alanen, 1994, Early Treatment for Schizophrenic Patients: Scandinavian Psychotherapeutic Approach
  31. Lehtinen, 1998, Using psychosis teams in early intervention. A follow-up study of the Finnish schizophrenia project, Nordic Journal of Psychiatry, 52, 74
  32. Jackson, 1996, Cognitively oriented psychotherapy for early psychosis (cope)
  33. Cullberg, 1998, Symposium 7: early detection and intervention in psychosis. 'the parachute project' - a Swedish multicenter project for first episode psychosis, Nordic Journal of Psychiatry, 52, 73
  34. Cullberg, 2000, Integrating intensive psychosocial and low-dose neuroleptic treatment: a three-year follow-up, 200
  35. Davidson M Reducing the risk of early transition to psychosis: using long-acting atypical antipsychotics in young patients Proceedings of the Thematic Conference of the World Psychiatric Association on 'Treatments in Psychiatry: An Update'; 2004 Nov 10-13; Florence, Italy 2004
  36. Haan, 1997, Early intervention, social functioning, psychotic relapse and suicide of patients with recent onset schizophrenia and other psychotic disorders, Tijdschrift voor Psychiatrie, 39, 24
  37. Emsley, 2004, Risk for akathisia in patients with recent onset schizophrenia treated with risperidone and haloperidol and its association with suicidality, Schizophrenia Research, 67, 183
  38. Fresan, 2001, Family environment and psychoeducation in first-episode schizophrenia: preliminary results, Salud Mental, 24, 36
  39. Gaebel, 2005, Pharmacological long-term treatment strategies in first episode schizophrenia: preliminary results of an ongoing randomised clinical trial within the german research network on schizophrenia, Schizophrenia Bulletin, 31, 483
  40. Grawe, 1998, Result of two years optimal out-patient treatment of first episode schizophrenia: a controlled study, Nordic Journal of Psychiatry Supplement, 52, 76
  41. Hartmann, 1974, The therapy of first time hospitalized schizophrenics, Fortschritte der Neurologie Neurologie und Medizinische Psychologie, 42, 601
  42. Kauranen, 2000, The change of social network of first episode psychotic patients in a network oriented treatment, Psykologia, 35, 403
  43. Keefe RSE Treatment of neurocognitive deficits with olanzapine or haloperidol in first episode psychosis Proceedings of the Second International Conference on Early Psychosis; 2000 31st March - 2nd April; New York, USA 2000
  44. Li, 2004, Effects of the nursing care of mutual participation model on the rehabilitation of inpatients with early schizophrenia, Zhongguo Linchuang Kangfu, 8, 4958
  45. Malla A Norman R McLean T Manchanda R Townsend L Cortese L Harricharan R Takhar J Development of a community focussed early intervention program for psychosis: combining service, research and public education Proceedings of the Second International Conference on Early Psychosis; 2000 31st March - 2nd April; New York, USA 2000
  46. Francey, 1999, The role of day programmes in recovery in early psychosis, 407
  47. Bola JR Evaluation of treatment in early episode acute psychosis: a secondary analysis of the soteria study Dissertation Abstracts International (Humanities and Social Sciences) 1999
  48. Mottaghipour Y Woodland L Sara G Efficacy and effectiveness in early psychosis family education group program Proceedings of the Second International Conference on Early Psychosis; 2000 31st March - 2nd April; New York, USA 2000
  49. Nuechterlein, 2005, Advances in improving and predicting work outcome in recent - onset schizophrenia, Schizophrenia Bulletin, 31, 31
  50. Lieberman J Sanger T Tohen M The First Episode Collaborative Study Group Olanzapine and haloperidol treatment of first episode schizophrenia and schizoaffective disorder: 12 week outcome of a two year randomized double blind trial Proceedings of the Second International Conference on Early Psychosis; 2000 31st March - 2nd April; New York, USA
  51. Sanger T Olanzapine versus haloperidol treatment in first episode psychosis [poster] Proceedings of the Second International Conference on Early Psychosis; 2000 31st March - 2nd April; New York, USA
  52. Sanger T Treatment of neurocognitive deficits with olanzapine or haloperidol in first episode psychosis Proceedings of the Second International Conference on Early Psychosis; 2000 31st March - 2nd April; New York, USA
  53. Thomas, 1979, Loxapine oral liquid concentrate in the treatment of young adult patients with acute schizophrenic symptoms, Current Therapeutic Research, 25, 371
  54. Opjordsmoen S Brunsvik S Melle I Dahl A Friis S Haahr U Hustoft K Johannessen JO Larsen TK McGlashan TH Simonsen E Vaglum P A comparison between novel and traditional antipsychotics as first-line medication in early psychosis Proceedings of the Second International Conference on Early Psychosis; 2000 31st March - 2nd April; New York, USA 2000
  55. Wang L Wang Z Risperidone versus clozapine treatment in first-episode psychosis Proceedings of the Second International Conference on Early Psychosis; 2000 31st March - 2nd April; New York, USA 2000
  56. Whitehorn D Establishing an early psychosis program in Nova Scotia Proceedings of the Second International Conference on Early Psychosis; 2000 31st March - 2nd April; New York, USA 2000
  57. Whitwell D Early intervention on a shoestring Proceedings of the Second International Conference on Early Psychosis; 2000 31st March - 2nd April; New York, USA
  58. Dai, 2007, A study on influence of early comprehensive interventions on prognosis of incipient schizophrenia patients, Chinese Nursing Research, 21, 2393
  59. Deng, 2006, Research the effect of early intervention of first episode schizophrenia, Medical Journal of Chinese Civil Administration, 18, 794
  60. Doering, 1998, Pradiktoren fur rezidiv und rehospitalisierung bei schizophrenie und schizoaffektiver psychose, Psychiatria Danubina, 10, 419
  61. Edwards J Early psychosis service developments: becoming real Proceedings of the 3rd International Conference on Early Psychosis; 2002 Sep 25-28; Copenhagen, Denmark 2003
  62. Fillatre, 1998, First acute psychotic disorder of the young, Annales de Psychiatrie, 13, 256
  63. Lee H Protective and risk factors in adolescents with schizophrenia Dissertation Abstracts International: Section B: The Sciences and Engineering
  64. Li, 2004, Effect of early intervention on quality of life in patients with first episode schizophrenia, Zhongguo Linchuang Kangfu, 8, 3464
  65. Li, 2007, Effect of early psychotherapy on post-schizophrenia depression, Chinese Journal of Health Psychology, 15, 24
  66. Tao, 2004, Effect of early intervention on quality of life in patients with first episode schizophrenia, Chinese Journal of Clinical Rehabilitation, 8, 3464
  67. Andreasen, 1983, Schedule for the Assessment of Negative Symptoms
  68. Deeks J Issues in the selection for meta-analyses of binary data Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28th; Cape Town 2000
  69. Department of Health, 2000, The NHS plan: a summary
  70. Edwards, 2000, Models of early intervention in psychosis: an analysis of service approaches, 281
  71. Edwards, 2002, Multi-component early intervention - models of good practice, 63, 10.1201/b14315-5 · DOI
  72. Falloon, 1984, Family Care of Schizophrenia
  73. Guy, 1970, Manual for the ECDEU Assessment Battery 2
  74. Guy, 1976, ECDEU Assessment Manual for Psychopharmacology (DOTES: Dosage Record and Treatment Emergent Symptom Scale)
  75. Kay, 1986, Positive and negative syndrome scale (PANSS) manual
  76. National Institute for Clinical Excellence, 2002, Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care
  77. The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008

Cited by

Sorted by citations

Items 401–500 of 528

Related

See all

Metadata

Authors
Marshall, M., & Rathbone, J.
Affiliations
  • University of Manchester (GB)
  • University of Sheffield (GB)
ORCID
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2011-06-15
Volume
2011
Issue
6
Pages
1111-4
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
DOI
10.1002/14651858.cd004718.pub3
PMC
PMC4163966
OpenAlex
W2125959313
Cited by
531
References
261
Citations by year
2026: 5 · 2025: 14 · 2024: 10 · 2023: 6 · 2022: 22 · 2021: 17 · 2020: 25 · 2019: 35 · 2018: 19 · 2017: 21 · 2016: 42 · 2015: 45 · 2014: 48 · 2013: 40 · 2012: 51
FWCI
6.98
Type
journal article
Language
en
Open access
Locations
  • Cochrane Database of Systematic Reviews (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
Keywords
early intervention, psychosis, schizophrenia, prodromal symptoms, first-episode psychosis, early detection, olanzapine, risperidone, cognitive behavioral therapy, antipsychotic drugs, treatment outcomes, adverse effects, hospitalization, social functioning, quality of life
MeSH terms
Humans, Psychotic Disorders, Schizophrenia, Time Factors, Cognitive Behavioral Therapy, Randomized Controlled Trials as Topic, Early Diagnosis, Suicidal Ideation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review